| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Loss before provision for income taxes | -56,857 | -11,517 | - | -48,787 |
| (benefit) from / provision for income taxes | 0 | -18 | - | - |
| Net loss | -56,857 | -11,499 | -75,968 | -48,787 |
| Net loss per share, basic | -0.67 | -0.14 | -0.91 | -0.59 |
| Net loss per share, diluted | -0.67 | -0.14 | -0.91 | -0.59 |
| Weighted average number of shares outstanding, basic, total | 84,869,864 | 84,580,125 | 83,106,013 | 82,043,671 |
| Weighted-average shares used to compute diluted eps | 84,869,864 | 84,580,125 | 83,106,013 | 82,043,671 |
SUTRO BIOPHARMA, INC. (STRO)
SUTRO BIOPHARMA, INC. (STRO)